Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 4:16 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1489–1512 of 8,269 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Risk Clear all

Conditions: Caries, Metabolomic Profile
Interventions: Drinking water, Apple juice; Other
Lead sponsor: Jodi Stookey; Government
Eligibility: 5 Years to 10 Years
Enrollment: 105 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Smoking, Body Weight
Interventions: Smoking Cessation, Smoking Cessation plus Weight Loss; Behavioral
Lead sponsor: University of Tennessee; Other
Eligibility: 18 Years to 35 Years
Enrollment: 330 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Heart Failure, Hyperkalemia
Interventions: Not listed
Lead sponsor: Vifor (International) Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 2,636 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 52
States / cities: Little Rock, Arkansas • La Jolla, California • Northridge, California + 46 more

Conditions: Depression, Major Depressive Disorder
Interventions: MoodTriggers Application; Other
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 320 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Hanover, New Hampshire • Lebanon, New Hampshire

Conditions: Substance Use Disorder, Posttraumatic Stress Disorder
Interventions: Prolonged Exposure with Contingency Management, Standard Care; Behavioral
Lead sponsor: UConn Health; Other
Eligibility: 18 Years to 25 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 3
States / cities: Farmington, Connecticut • Hartford, Connecticut • New Britain, Connecticut

Conditions: West Syndrome
Interventions: adrenocorticotropin hormone; Drug
Lead sponsor: Ann & Robert H Lurie Children's Hospital of Chicago; Other
Eligibility: 2 Months to 12 Months
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Prediabetes
Interventions: FUERTE Arm, Standard care, No Intervention; Behavioral · Other
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 99 Years · Male only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: New York, New York

Conditions: High Risk Cervical Cancer, Advanced Cervical Cancer
Interventions: ADXS11-001, Placebo; Drug
Lead sponsor: Advaxis, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 41
States / cities: Mobile, Alabama • Phoenix, Arizona • Duarte, California + 35 more

Conditions: Leukemia
Interventions: Pacritinib, 5-azacitidine, Decitabine; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Human Immunodeficiency Virus, Sexually Transmitted Infections, Anxiety, Depression, Substance Use Disorders
Interventions: Project PRIDE; Behavioral
Lead sponsor: University of Houston; Other
Eligibility: 18 Years to 25 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: Danirixin, Placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 40 Years to 70 Years
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 6
States / cities: Birmingham, Alabama • Denver, Colorado • Iowa City, Iowa + 3 more

Conditions: Glaucoma
Interventions: ComBaT Glaucoma; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 40 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: Ann Arbor, Michigan • Detroit, Michigan

Conditions: Hereditary Diseases
Interventions: Audiotaped Focus Group, Demographic Questionnaire, Audiotaped Interview, WAMMI Inventory; Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2021
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Colorectal Cancer
Interventions: fluorouracil, leucovorin calcium, levamisole hydrochloride; Drug
Lead sponsor: SWOG Cancer Research Network; Network
Eligibility: 18 Years and older
Enrollment: 1,135 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1994 – 2005
U.S. locations: 57
States / cities: Scottsdale, Arizona • Palo Alto, California • San Francisco, California + 48 more

Conditions: Female Sexual Dysfunction
Interventions: Not listed
Lead sponsor: St. Louis University; Other
Eligibility: 18 Years to 89 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Type1 Diabetes Mellitus
Interventions: Beta Cell Loss and Immune Function, Immune Function with RNAseq; Diagnostic Test · Other
Lead sponsor: University of Exeter; Other
Eligibility: Up to 70 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2028
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Cytomegalovirus Disease
Interventions: Valganciclovir, CMV hyperimmune globulin; Drug · Biological
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Hodgkin Lymphoma
Interventions: doxorubicin, Bleomycin, vinblastine, dacarbazine, Nivolumab; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2027
U.S. locations: 9
States / cities: Detroit, Michigan • Basking Ridge, New Jersey • Hackensack, New Jersey + 6 more

Conditions: Cardiovascular Risk Factor, Cardiovascular Diseases, Adverse Effect
Interventions: Rosuvastatin 20mg, Placebo; Drug · Other
Lead sponsor: Minneapolis Heart Institute Foundation; Other
Eligibility: 21 Years to 75 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Substance Abuse, HIV Infections
Interventions: Aripiprazole, Placebo; Drug
Lead sponsor: San Francisco Department of Public Health; Government
Eligibility: 18 Years to 60 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: San Francisco, California

Conditions: HIV/AIDS
Interventions: PrEP standard of care+behavioral intervention; Behavioral
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 18 Years and older · Female only
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Obesity, Type 2 Diabetes
Interventions: HEALTH[e]TEEN, HEALTH[e]TEEN + CST; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 13 Years to 18 Years
Enrollment: 384 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Major Depressive Episode
Interventions: Text Messaging Intervention; Other
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 16 Years to 45 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Prostate Cancer
Interventions: Androgen deprivation therapy; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older · Male only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2006
U.S. locations: 2
States / cities: Boston, Massachusetts

Search by objective public record fields.

Saliva Insulin as Biomarker of Risk Factors for Metabolic Dysregulation and Caries

Treating Adults at Risk for Weight Gain With Interactive Technology

Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalaemia or at High Risk of Hyperkalaemia

Remote Evaluation and Alerting for Collaborative Health (REACH) in Depression

Integrated Treatment for Posttraumatic Stress Disorder and Substance Abuse in Young Adults

Prevention of West Syndrome With Low-dose Adrenocorticotropin Hormone (ACTH)

Piloting FUERTE: Federally qUalified Health Centers Engaging Hispanic Men at Risk of diabeTEs

Study of ADXS11-001 in Participants With High Risk Locally Advanced Cervical Cancer

Pacritinib for Patients With Lower-Risk Myelodysplastic Syndromes (MDS)

Project PRIDE (Promoting Resilience In Discriminatory Environments)

Investigation of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of Oral Danirixin in Symptomatic COPD Subjects With Mild to Moderate Airflow Limitation at Risk for Exacerbations

Community Based Treatment for (ComBaT) Glaucoma

A Social Media Approach to Improve Genetic Risk Communication Phase I

S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed

Female Sexual Dysfunction, Risks and Outcomes (FSFI)

EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)

Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for Cytomegalovirus Infection

A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL)

The DEtermining Statin Intolerance FOr Rosuvastatin (DESIFOR) Trial

Aripiprazole Treatment for Methamphetamine Dependence Among High-risk Individuals

Developing a PrEP Adherence Intervention Targeting At-Risk and Substance Using Women

Reducing Obesity and Type 2 Diabetes in High Risk Youth

A Text Messaging Intervention to Reduce Perinatal Depression Risk

Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer